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Approximately 3% of the population of England have their origins
in the Indian subcontinent. To date, only proportional mortality
and standardized mortality ratios based on country of origin have
been described (Balarajan et al, 1984; Swerdlow et al, 1995;
Balarajan et al, 1997), and there has been no comprehensive study
of cancer incidence in this population. Published studies on inci-
dence are limited to relatively small numbers because they were
based on specific geographical areas (Donaldson et al, 1984;
Matheson et al, 1985; Barker et al, 1990) or on children alone
(Stiller et al, 1991; Muir et al, 1992; Powell et al, 1994; Varghese
et al, 1996). One non-UK study has examined cancer incidence in
migrants to Australia from a number of Asian countries including
India and Sri Lanka (Grulich et al, 1995). For the first time, the
1991 census provided population figures based on ethnic origin
(OPCS, 1993a). In this study, we combined these denominator
figures with numerator data from cancer registrations in the years
1990—92 to study the incidence rates of cancer among south
Asians in four regional cancer registries in England.
As the study population incorporates approximately 80% of the
south Asian population resident in England, our estimates on inci-
dence should be more precise than those available hitherto. The
results constitute an important baseline for monitoring trends and
health care needs assessment in these ethnic groups. Comparison
of standardized rates with those for the Indian subcontinent and
the non-south Asian study population would also serve to indicate
how rates in south Asians have changed with migration and should
provide data for the generation of aetiological hypotheses.
PATIENTS AND METHODS
For the purpose of this study, a south Asian was defined as a
person, irrespective of birthplace, with an ethnic origin in peoples
indigenous to India, Pakistan or Bangladesh.
The study population consisted of those persons resident in
areas covered by Thames, Trent, West Midlands and Yorkshire
cancer registries, representing approximately 57% of the total
population of England. As cancer registry data on ethnic origin
were largely incomplete, cancer cases were classified as south
Asian if their names were identified as having an Indian, Pakistani
or Bangladeshi, but not Sri Lankan, origin.
The full list of cancer registrations for the four regions
(1990—92) was run against the Nam Pehchan computer software
package (Bradford Health Authority) (subsequently referred to as
Nam Pehchan), developed by Bradford Health Authority and the
City of Bradford Metropolitan Council, to identify partial or
complete matches against the program￿s dictionary of south Asian
names. In a pilot study, Nam Pehchan achieved 91.0% sensitivity,
99% specificity and a positive predictive value of 87.5% when run
against a West Midlands childhood cancer data set in which
ethnicity had been identified by the West Midlands Regional
Children￿s Tumour Research Group from hospital notes and
consultations (440 south Asian cases out of a total of 6437). As the
program￿s dictionary of names may not yet be fully comprehen-
sive and as some names were classified as south Asian on the basis
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B15 2TT, UKof a partial stem match, the entire dataset was also screened using
the strategy which follows.
A dictionary of common non-south Asian names was gener-
ated from the full list of names and used to exclude those
program negatives in which all component names, i.e.
surname/forename(s)/maiden name, matched against an entry in
the non-south Asian dictionary. The full list of program positives
and those program negatives not excluded by the above proce-
dure was visually inspected and cases classified as non-south
Asian in which all component names were independently identi-
fied as non-south Asian by three members of the research team.
The full list of remaining names, excluding those classified as
non-south Asian by one of the above procedures, was submitted
to a panel for final classification. The panel was made up of three
core members representing the main south Asian religious
groups found in the United Kingdom (Hindu/Moslem/Sikh) 
and five additional contributors with knowledge of a range of
south Asian and non-south Asian Moslem populations. Books,
providing lists of Hindu/Moslem/Sikh names were available
throughout, to both researchers and panel members (Patel, 1992;
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Table 1 Age-standardized incidence rates (males) per 100 000 person–years (1990–92)
English registries Indian
South Asian Non-south Asian registry
ICD9 Site n Rate 95% CI n Rate 95% CI rangea
140 Lip 0 135 0.2 0.1–0.3 0.0–0.6
141 Tongue 23 1.7 0.9–2.5 635 1.1 1.0–1.3 3.4–14.0
142 Salivary glands 9 0.8 0.2–1.4 289 0.5 0.4–0.6 0.3–0.7
143–5 Mouth 26 1.9 1.0–2.7 838 1.5 1.4–1.7 4.4–6.9
146 Oropharynx 5 0.5 0.0–1.0 414 0.8 0.6–0.9 1.7–6.2
147 Nasopharynx 9 0.5 0.1–0.8 187 0.4 0.3–0.5 0.5–0.7
148 Hypopharynx 21 2.0 1.0–3.0 331 0.6 0.4–0.7 5.3–10.8
149 Other mouth/pharynx 5 0.4 0.0–0.9 169 0.3 0.2–0.4 0.6–2.2
150 Oesophagus 39 3.3 2.1–4.5 4878 7.7 7.5–8.0 7.6–11.4
151 Stomach 70 5.6 4.2–7.1 9622 14.4 14.1–14.8 2.1–15.1
152 Small intestine 4 0.3 0.0–0.6 325 0.5 0.4–0.6 0.2–0.3
153 Colon 88 7.4 5.7–9.1 12 191 18.6 18.2–19.0 1.5–3.2
154 Rectum 65 4.9 3.6–6.2 9038 14.2 13.9–14.6 2.4–4.6
155 Liver 85 6.2 4.7–7.7 1219 2.0 1.8–2.2 1.7–3.4
156 Gall bladder 26 2.2 1.2–3.2 845 1.3 1.1–1.4 0.4–1.0
157 Pancreas 47 4.4 3.0–5.8 4733 7.3 7.1–7.6 0.7–2.5
158 Peritoneum 9 0.5 0.1–0.9 185 0.3 0.2–0.4 0.3–0.7
160 Nasal cavities 6 0.5 0.0–0.9 341 0.6 0.5–0.7 0.6–1.0
161 Larynx 48 3.9 2.6–5.1 2386 4.0 3.8–4.2 4.3–10.2
162 Trachea/bronchus/lung 344 30.1 26.7–33.5 38 249 58.1 57.5–58.8 8.5–14.0
163 Pleura 10 0.8 0.2–1.3 1168 2.0 1.8–2.2 0.1–0.8
164 Thymus/heart/mediastinum 4 0.3 0.0–0.6 153 0.3 0.2–0.4 0.1–0.2
170 Bone 21 1.1 0.6–1.6 344 0.8 0.7–0.9 0.7–1.2
171 Connective/soft tissue 33 2.1 1.3–3.0 903 1.8 1.6–1.9 0.9–2.4
172 Melanoma of skin 7 0.6 0.1–1.1 2096 4.0 3.8–4.2 0.2–0.4
173 Non-melanoma skin 26 2.0 1.1–2.9 15 772 25.0 24.6–25.5 1.2–1.9
175 Male breast 3 0.2 0.0–0.6 321 0.5 0.4–0.6 0.2–0.5
185 Prostate 159 16.7 13.9–19.4 21 447 29.0 28.6–29.5 2.1–6.9
186 Testis 28 1.7 0.9–2.5 1990 4.4 4.2–4.7 0.6–1.0
187 Penis, other male genital 5 0.5 0.0–1.1 513 0.9 0.7–1.0 1.7–2.8
188 Bladder 102 8.4 6.6–10.2 12 614 19.2 18.8–19.6 1.8–3.6
189 Kidney 49 3.3 2.3–4.4 4032 6.9 6.6–7.2 1.1–1.4
190 Eye 9 0.6 0.1–1.0 323 0.7 0.5–0.8 0.1–0.6
191–2 Brain/nervous system 95 5.5 4.3–6.8 2981 6.2 5.9–6.5 1.3–2.4
193 Thyroid gland 13 0.8 0.3–1.3 333 0.6 0.5–0.7 0.5–0.9
194 Other endocrine glands 10 0.6 0.2–1.0 271 0.7 0.5–0.8 0.1–1.6
200–3 Lymphoma 246 16.8 14.5–19.1 8335 15.0 14.6–15.4 4.8–5.7
201 Hodgkin’s disease 64 3.5 2.5–4.4 1028 2.4 2.1–2.5 1.2–1.6
200/2 Non-Hodgkin’s lymphoma 143 9.9 8.1–11.7 5305 9.5 9.2–9.8 2.6–3.7
203 Multiple myeloma 39 3.4 2.2–4.6 2002 3.1 2.9–3.3 0.7–0.9
204–8 Leukaemia 106 6.9 5.4–8.4 4045 7.4 7.1–7.7 2.7–4.0
204 Lymphoid leukaemia 55 3.3 2.3–4.3 1851 3.7 3.5–4.0 1.0–1.6
205 Myeloid leukaemia 50 3.5 2.4–4.7 1951 3.3 3.1–3.5 1.1–1.8
206–8 Other leukaemia 1 0.1 0.0–0.3 243 0.4 0.3–0.5 0.3–0.7
Primary site uncertainb 103 8.7 6.8–10.6 10 414 15.9 15.5–16.3 6.0–25.2
All sites, excluding 173 1932 152.8 145.3–160.2 159 293 250.9 249.5–252.2 93.9–140.7
n represents number of cases. aIndian rates are based on 1983–87 data. bPrimary site uncertain includes the following ICD9 codes: 159,
165, 195–199.Gandhi, 1993; Dimpy, 1994; Gandhi and Husain, 1994; Kanath,
1996). Classification of the small proportion of names consid-
ered to be mixed, for example a non-south Asian forename in
combination with a south Asian surname, was undertaken on 
an individual basis after consultation with panel members.
Approximately 80% of the names identified as mixed were
female, with a non-south Asian forename in conjunction with a
south Asian surname being the most common combination.
Where this combination was observed together with a maiden
name, the name was classified on the basis of the maiden name.
Thus, those with a south Asian maiden name were generally clas-
sified as south Asian, and those with a non-south Asian maiden
name were classified as non-south Asian. The majority of mixed
names with a Christian forename and Moslem surname were
classified as non-south Asian because this was considered to be
an unlikely combination in a person of true south Asian Moslem
ethnic origin.
The denominator for the incidence estimates was derived from
the 1991 census, utilizing data available at regional health
authority (RHA) level. All those who identified their ethnic
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Table 2 Age-standardized incidence rates (females) per 100 000 person–years (1990–92)
English registries Indian
South Asian Non-south Asian registry
ICD9 Site n Rate 95% CI n Rate 95% CI rangea
140 Lip 0 53 0.1 0.0–0.1 0.1–0.5
141 Tongue 25 1.9 1.1–2.8 407 0.5 0.4–0.6 1.1–2.5
142 Salivary glands 6 0.4 0.0–0.9 266 0.4 0.3–0.5 0.4–0.5
143–5 Mouth 29 2.8 1.7–3.9 509 0.7 0.6–0.8 3.7–9.6
146 Oropharynx 5 0.4 0.0–0.9 154 0.2 0.1–0.3 0.3–1.1
147 Nasopharynx 2 0.1 0.0–0.3 102 0.2 0.1–0.3 0.2–0.4
148 Hypopharynx 7 0.5 0.1–1.0 194 0.3 0.2–0.4 1.2–2.2
149 Other mouth/pharynx 2 0.2 0.0–0.5 86 0.1 0.0–0.2 0.3–0.7
150 Oesophagus 47 4.6 3.1–6.0 3342 3.3 3.2–3.5 5.6–8.8
151 Stomach 40 4.1 2.7–5.4 5968 5.6 5.4–5.8 1.5–6.7
152 Small intestine 3 0.2 0.0–0.6 279 0.3 0.2–0.4 0.1–0.3
153 Colon 49 4.2 2.9–5.5 14 188 14.9 14.5–15.2 1.0–2.6
154 Rectum 33 3.0 1.8–4.1 6876 7.7 7.4–7.9 1.9–2.7
155 Liver 24 2.4 1.3–3.4 763 0.9 0.8–1.0 0.8–1.9
156 Gall bladder 39 3.7 2.4–4.9 1074 1.1 1.0–1.3 0.5–1.7
157 Pancreas 36 3.7 2.4–5.0 4958 5.1 4.9–5.3 0.2–1.5
158 Peritoneum 4 0.2 0.0–0.4 184 0.3 0.2–0.4 0.3–0.5
160 Nasal cavities 2 0.2 0.0–0.5 253 0.3 0.2–0.4 0.4–0.9
161 Larynx 8 0.8 0.2–1.3 542 0.7 0.6–0.9 0.6–1.6
162 Trachea/bronchus/lung 68 6.9 5.2–8.7 17 835 21.6 21.1–22.0 1.4–3.0
163 Pleura 2 0.2 0.0–0.5 309 0.4 0.3–0.5 0.1–0.6
164 Thymus/heart/mediastinum 3 0.2 0.0–0.5 108 0.2 0.1–0.3 0.0–0.1
170 Bone 11 0.6 0.2–1.1 281 0.6 0.5–0.8 0.6–1.0
171 Connective/soft tissue 26 1.6 0.9–2.3 770 1.3 1.1–1.4 0.7–1.2
172 Melanoma of skin 8 0.6 0.1–1.1 3171 5.4 5.1–5.6 0.2–0.4
173 Non-melanoma skin 29 2.5 1.5–3.5 14 879 17.7 17.3–18.0 1.1–1.7
174 Female breast 631 46.6 42.7–50.5 46 108 72.9 72.1–73.7 18.2–24.6
179 Uterus, part unspecified 10 0.8 0.2–1.3 455 0.7 0.5–0.8 0.4–1.3
180 Cervix 107 8.0 6.3–9.6 5548 10.2 9.9–10.5 19.3–47.2
181 Placenta 1 <0.1 0.0–0.2 7 <0.1 0.0–0.1 0.2–0.3
182 Body of uterus 76 6.6 5.0–8.2 5855 8.4 8.1–8.7 1.6–2.3
183 Ovary 104 8.0 6.3–9.7 8061 12.2 11.9–12.6 4.0–6.5
184 Other female genital 11 1.2 0.4–1.9 1570 1.7 1.5–1.8 1.3–2.2
188 Bladder 22 1.9 1.0–2.7 4936 5.2 5.0–5.4 0.5–0.9
189 Kidney 29 2.6 1.5–3.7 2420 3.3 3.1–3.5 0.6–0.9
190 Eye 1 0.1 0.0–0.3 351 0.6 0.5–0.7 0.1–0.4
191–2 Brain/nervous system 46 3.0 2.0–3.9 2161 4.2 4.0–4.5 0.7–1.7
193 Thyroid gland 42 3.0 1.9–4.0 980 1.6 1.5–1.8 1.3–2.8
194 Other endocrine glands 2 0.1 0.0–0.3 247 0.5 0.4–0.7 0.0–0.1
200–3 Lymphoma 107 8.9 7.0–10.8 7077 9.8 9.5–10.1 2.3–3.8
201 Hodgkin’s disease 23 1.4 0.7–2.0 724 1.6 1.4–1.8 0.5–0.7
200/2 Non-Hodgkin’s lymphoma 64 5.6 4.1–7.1 4470 6.1 5.8–6.4 1.2–2.3
203 Multiple myeloma 20 1.9 1.0–2.9 1883 2.1 1.9–2.3 0.4–0.9
204–8 Leukaemia 84 5.6 4.3–7.0 3188 4.6 4.3–4.8 1.9–2.8
204 Lymphoid leukaemia 32 2.1 1.3–2.9 1308 2.0 1.8–2.2 0.5–1.0
205 Myeloid leukaemia 50 3.4 2.3–4.5 1683 2.3 2.2–2.5 1.0–1.5
206–8 Other leukaemia 2 0.2 0.0–0.4 197 0.2 0.1–0.3 0.3–0.4
Primary site uncertainb 106 10.2 8.1–12.3 11 130 11.5 11.2–11.8 3.6–14.7
All sites, excluding 173 1858 149.9 142.6–157.3 16 2766 219.6 218.3–220.9 108.9–127.2
n represents number of cases. aIndian rates are based on 1983–87 data. bPrimary site uncertain includes the following ICD9 codes:
159,165,195–199.origin as Indian, Pakistani and Bangladeshi as well as a propor-
tion of a fourth census grouping (other groups Asian, namely
East African Asian and Indian subcontinent) were classified as
south Asian. To allow for census undercoverage, each RHA was
partitioned into its constituent local authority areas (OPCS,
1993b) and an appropriate adjustment factor for estimated
undercoverage by area type, sex and age group was applied
(OPCS, 1994).
Age-specific rates and rates directly standardized to the world
standard population with 95% confidence intervals were calcu-
lated for malignant neoplasms. Age-standardized rates provide a
standard method for presenting cancer rates and allow comparison
of results with published data. For each cancer site, the null
hypothesis of equal incidence rates for south Asians and non-south
Asians was tested against the alternative hypothesis of propor-
tional age-specific rates using a Mantel—Haenszel test (Esteve et
648 H Winter et al
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Table 3 Cancer sitesa ranked by percentage of total south Asian cases
(males)
South Percentage of cases Non-
Asian South Non- south Asian
rank Site Asian South Asian rank
1 Lung 17.8 24.0 1
2 Lymphoma 12.7 5.2 6
3 Prostate 8.2 13.5 2
4 Colorectal 7.9 13.3 3
5 Leukaemia 5.5 2.5 9
6 Bladder 5.3 7.9 4
7 Lip, oral cavity, pharynx 5.1 1.9 11
8 Brain/nervous system 4.9 1.9 12
9 Liver 4.4 0.8 16
10 Stomach 3.6 6.0 5
aICD9: 140–208, excluding 173.
Table 4 Cancer sitesa ranked by percentage of total south Asian cases
(females)
South Percentage of cases Non-
Asian South Non- south Asian
rank Site Asian South Asian rank
1 Breast 34.0 28.3 1
2 Cervix 5.8 3.4 8
2= Lymphoma 5.8 4.4 5
4 Ovary 5.6 5.0 4
5 Leukaemia 4.5 2.0 12
6 Colorectal 4.4 12.9 2
7 Lip, oral cavity, pharynx 4.1 1.1 16
7= Body of uterus 4.1 3.6 7
9 Lung 3.7 11.0 3
10 Oesophagus 2.5 2.1 11
aICD9: 140–208, excluding 173.
Table 5 Age-specific rates per 100 000 person–years (1990–92) for the ten most common English south Asian sitesa (males)
Age group
Ethnic 0–14 15–29 30–49 50–74 75+
Site group n Rate n Rate n Rate n Rate n Rate
Lung South Asian 0 0.0 0 0.0 26 5.2 272 101.4 46 315.9
Non-south Asian 1 <0.1 21 0.2 1135 10.4 23 567 256.2 13 525 697.0
Lymphoma South Asian 23 3.7 31 6.2 58 11.6 119 44.4 15 103.0
Non-south Asian 128 1.7 571 6.1 1368 12.5 4159 45.2 2109 108.7
Prostate South Asian 0 0.0 0 0.0 1 0.2 105 39.1 53 364.0
Non-south Asian 2 <0.1 3 <0.1 70 0.6 9837 106.9 11 535 594.4
Colorectal South Asian 0 0.0 7 1.4 27 5.4 103 38.4 16 109.9
Non-south Asian 1 <0.1 38 0.4 1065 9.7 12 313 133.8 7812 402.6
Leukaemia South Asian 36 5.8 11 2.2 16 3.2 38 14.2 5 34.3
Non-south Asian 326 4.4 200 2.1 378 3.5 1792 19.5 1349 69.5
Bladder South Asian 0 0.0 3 0.6 14 2.8 69 25.7 16 109.9
Non-south Asian 2 <0.1 18 0.2 500 4.6 7195 78.2 4899 252.5
Lip/oral cavity/ South Asian 1 0.2 3 0.6 25 5.0 56 20.9 13 89.3
pharynx Non-south Asian 12 0.2 46 0.5 425 3.9 1903 20.7 612 31.5
Brain/nervous South Asian 19 3.1 11 2.2 30 6.0 35 13.1 0 0.0
system Non-south Asian 178 2.4 227 2.4 599 5.5 1698 18.5 279 14.4
Liver South Asian 2 0.3 3 0.6 9 1.8 64 23.9 7 48.1
Non-south Asian 12 0.2 14 0.2 87 0.8 760 8.3 346 17.8
Stomach South Asian 0 0.0 4 0.8 18 3.6 39 14.5 9 61.8
Non-south Asian 1 <0.1 18 0.2 332 3.0 5424 59.0 3847 198.2
All sites South Asian 114 18.4 111 22.3 296 59.0 1182 440.6 229 1572.7
excluding 173 Non-south Asian 944 12.7 2332 25.0 10 022 91.6 88 777 965.0 57 218 2948.5
aICD9: 140–208, excluding 173.al, 1994). In effect, the Mantel—Haenzsel test represents a compar-
ison of two age-specific rate curves. For comparison, incidence
rates from four cancer registries in India (Ahmedabad, Bombay,
Bangalore, Madras) were obtained from published sources (Parkin
et al, 1992).
RESULTS
The Nam Pehchan computer software package identified 5506
south Asian names from the 356 555 names considered in total.
After visual inspection, 3482 program positives were confirmed as
south Asian and 363 program negatives were also classified as
south Asian, yielding a total of 3845 south Asian names in the final
classification (1.1%). Using the final classification as reference,
Nam Pehchan achieved an overall sensitivity, specificity and posi-
tive predictive value of 90.5%, 99.4% and 63.2% respectively.
Age-standardized rates for the major cancer sites are presented
in Tables 1 and 2, together with the range of rates for four Indian
cancer registries.
Comparison of south Asian and non-south Asian rates
(England)
In males, incidence rates were significantly lower in south Asians
compared with non-south Asians for all sites combined and for
cancer of the oesophagus, stomach, colon, rectum, pancreas, lung,
melanoma of the skin, prostate, testis, bladder and kidney 
(P < 0.001), and for cancer of the pleura (P < 0.01). Rates were
significantly higher in south Asian males for cancer of the
hypopharynx and liver (P < 0.001), and for cancer of the gall
bladder and Hodgkin￿s disease (P < 0.01).
In females, incidence rates were significantly lower in south
Asians compared with non-south Asians for all sites combined and
for cancer of the colon, rectum, lung, melanoma of the skin, breast,
cervix, ovary and bladder (P < 0.001), and for cancer of the stomach,
body of uterus, eye, brain/nervous system and other endocrine glands
(P < 0.05). Rates were significantly higher in south Asian females for
cancer of the tongue, mouth, liver and gall bladder (P < 0.001), for
cancer of the thyroid gland and myeloid leukaemia (P < 0.01) and for
cancer of the hypopharynx and oesophagus (P < 0.05).
A summary of the numerically most important cancer sites is
provided in Tables 3 and 4. Differences between south Asians and
non-south Asians included the greater relative importance of
breast cancer in south Asian females and the higher rank of
lymphoma for south Asians of both sexes. Age-specific rates for
the most common south Asian sites and corresponding non-south
Asian rates are presented in Tables 5 and 6.
The observed and expected number of south Asian cases for
each cancer site are presented in Table 7, together with the ratio of
observed to expected cases expressed as a percentage. The
expected number of south Asian cases represent the total number
of cases that would have been observed if the age-specific rates for
the south Asian population had been equivalent to the age-specific
rates for the non-south Asian population. For example, the number
of south Asian male liver cancer cases (85) was more than three
times the expected number (26.9).
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Table 6 Age-specific rates per 100 000 person–years (1990–92) for the ten most common English south Asian sitesa (females)
Age group
Ethnic 0–14 15–29 30–49 50–74 75+
Site group n Rate n Rate n Rate n Rate n Rate
Breast South Asian 0 0.0 19 3.9 262 51.5 333 159.9 17 101.3
Non-south Asian 2 <0.1 271 3.0 8913 82.4 25 925 256.2 10 997 289.7
Cervix South Asian 0 0.0 3 0.6 45 8.9 56 26.9 3 17.9
Non-south Asian 0 0.0 412 4.6 2359 21.8 2042 20.2 735 19.4
Lymphoma South Asian 4 0.7 20 4.1 20 3.9 55 26.4 8 47.7
Non-south Asian 57 0.8 409 4.6 783 7.2 3279 32.4 2549 67.1
Ovary South Asian 3 0.5 5 1.0 31 6.1 58 27.9 7 41.7
Non-south Asian 12 0.2 155 1.7 1129 10.4 4767 47.1 1998 52.6
Leukaemia South Asian 28 4.8 12 2.5 16 3.2 23 11.1 5 29.8
Non-south Asian 236 3.4 142 1.6 264 2.4 1145 11.3 1401 36.9
Colorectal South Asian 0 0.0 1 0.2 23 4.6 49 23.5 9 53.6
Non-south Asian 0 0.0 30 0.3 951 8.8 9484 93.7 10 599 279.2
Lip/oral cavity/ South Asian 1 0.2 2 0.4 27 5.3 40 19.2 6 35.7
pharynx Non-south Asian 14 0.2 34 0.4 197 1.8 935 9.2 591 15.6
Body of uterus South Asian 0 0.0 2 0.4 17 3.3 53 25.5 4 23.8
Non-south Asian 0 0.0 18 0.2 444 4.1 3765 37.2 1628 42.9
Lung South Asian 0 0.0 0 0.0 7 1.4 49 23.5 12 71.5
Non-south Asian 0 0.0 11 0.1 701 6.5 10 632 105.1 6491 171.0
Oesophagus South Asian 0 0.0 2 0.4 2 0.4 34 16.3 9 53.6
Non-south Asian 0 0.0 3 <0.1 82 0.8 1416 14.0 1841 48.5
All sites South Asian 66 11.2 104 21.2 543 106.8 996 478.4 149 887.7
excluding 173 Non-south Asian 727 10.3 2339 26.3 19 398 179.3 82 046 810.8 58 256 1534.5
aICD9: 140–208, excluding 173.650 H Winter et al
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Table 7 Observed and expected number of south Asian cases by cancer site
South Asian males South Asian females
ICD9 Site Obs. Exp. % O/E Obs. Exp. % O/E
140 Lip 0 2.7 0 0 0.7 0
141 Tongue 23 16.1 143 25^^^ 6.9 360
142 Salivary glands 9 6.5 139 6 5.0 119
143–5 Mouth 26 21.1 123 29^^^ 8.3 349
146 Oropharynx 5 10.5 48 5 3.0 168
147 Nasopharynx 9 6.6 136 2 2.7 73
148 Hypopharynx 21^^^ 7.4 283 7^ 3.1 226
149 Other mouth/pharynx 5 3.7 136 2 1.1 177
150 Oesophagus 39*** 88.9 44 47^ 32.9 143
151 Stomach 70*** 156.8 45 40* 55.2 72
152 Small intestine 4 6.9 58 3 3.9 76
153 Colon 88*** 208.7 42 49*** 148.7 33
154 Rectum 65*** 165.5 39 33*** 79.1 42
155 Liver 85^^^ 26.9 316 24^^^ 10.6 226
156 Gall bladder 26^^ 14.7 177 39^^^ 12.0 326
157 Pancreas 47*** 83.5 56 36 49.5 73
158 Peritoneum 9 5.3 169 4 3.4 118
160 Nasal cavities 6 7.9 76 2 3.7 54
161 Larynx 48 49.9 96 8 8.0 100
162 Trachea/bronchus/lung 344*** 637.7 54 68*** 213.2 32
163 Pleura 10** 25.6 39 2 4.5 45
164 Thymus/heart/mediastinum 4 4.9 82 3 2.4 127
170 Bone 21 14.8 142 11 11.4 96
171 Connective/soft tissue 33 27.9 118 26 19.6 133
172 Melanoma of skin 7*** 60.9 12 8*** 81.2 10
173 Non-melanoma skin 26*** 293.5 9 29*** 201.3 14
174 Female breast 631*** 945.4 67
175 Male breast 3 6.0 50
179 Uterus, part unspecified 10 8.7 115
180 Cervix 107*** 171.8 62
181 Placenta 1 0.4 286
182 Body of uterus 76* 96.0 79
183 Ovary 104*** 151.3 69
184 Other female genital 11 18.4 60
185 Prostate 159*** 268.8 59
186 Testis 28*** 88.4 32
187 Penis, other male genital 5 10.8 47
188 Bladder 102*** 211.0 48 22*** 51.9 42
189 Kidney 49*** 87.8 56 29 37.7 77
190 Eye 9 10.4 86 1* 8.2 12
191–2 Brain/nervous system 95 99.8 95 46* 63.8 72
193 Thyroid gland 13 10.0 130 42^^ 26.4 159
194 Other endocrine gland 10 11.4 88 2* 8.3 24
200–3 Lymphoma 246 218.6 113 107 127.0 84
201 Hodgkin’s disease 64^^ 45.6 140 23 29.4 78
200/2 Non-Hodgkin’s lymphoma 143 136.5 105 64 76.1 84
203 Multiple myeloma 39 36.5 107 20 21.4 93
204–8 Leukaemia 106 104.9 101 84^ 63.9 131
204 Lymphoid leukaemia 55 54.2 102 32 29.0 110
205 Myeloid leukaemia 50 46.0 109 50^^ 32.4 155
206–8 Other leukaemia 1 4.7 21 2 2.5 80
Primary site uncertainb 103*** 178.9 58 106 117.8 90
All sites, excluding 173 1932*** 2967.8 65 1858*** 2667.2 70
^/*indicate higher/lower age-specific rates in south Asians compared with non-south Asians (see patients and methods) at the
following levels of statistical significance: ^/* (P <0.05), ^^/** (P < 0.01), ^^^/*** (P <0.001). %O/E is the ratio of observed to expected
number of cases. bincludes ICD9 codes 159,165,195–199.Incidence rates have been derived for a large number of cancer
sites and, as a consequence, some of the findings deemed to be
statistically significant may have occurred merely by chance. The
results as a whole are, however, consistent with the hypothesis that
rates in migrant populations are intermediate between rates in the
country of ethnic origin and those in the country of residence.
Further, raised English Asian rates for Hodgkin￿s disease in males,
cancer of the oral cavity and leukaemia in females, and for liver
and gallbladder cancer in both sexes confirm the findings of earlier
studies on cancer mortality in the migrant south Asian population
(Swerdlow et al, 1995; Balarajan et al, 1997).
Comparison of rates in England with rates for the
Indian subcontinent
For the majority of sites, standardized rates for south Asians resi-
dent in England (English south Asian) were higher than rates for
south Asians resident in India (Indian Asian), but lower than rates
for non-south Asians. For testicular cancer in males, lung and
ovarian cancer in females, and colorectal and bladder cancer in
both sexes, English south Asian rates were closer to, but higher
than, Indian Asian rates. For lung, prostate and kidney cancer in
males, breast and brain/nervous system cancer in females, and
pancreatic cancer in both sexes, English south Asian rates were
approximately midway between Indian Asian and non-south Asian
rates. For cancer of the brain/nervous system and leukaemia in
males and cancer of the uterus, kidney and lymphoma in females,
English south Asian rates were closer to, but lower than, non-south
Asian rates. For lymphoma in males and leukaemia in females,
English south Asian rates were higher than both Indian Asian and
non-south Asian rates.
Age-specific rates for English south Asian, non-south Asian and
Bombay males and females (all sites combined) are presented in
Figures 1 and 2. Non-south Asian rates were higher than Bombay
rates for both sexes over all age ranges. In males, English south
Asian rates were higher than non-south Asian rates in those under
20, below but closer to non-south Asian rates for ages 20—29, and
closer to Bombay rates for adults aged 30 and over. In females,
English south Asian rates were as high or higher than non-south
Asian rates in those under 14, below but closer to non-south Asian
rates for ages 15—29, closer to Bombay rates for adults aged 30—59
and midway between Bombay rates and non-south Asian rates for
those aged 60 and over.
DISCUSSION
In the absence of information on self-ascribed ethnicity, any
method of classification of ethnic group is subject to error. In addi-
tion, without information on period of residence and birthplace,
groups identified as south Asian will be heterogeneous, and
include important within-group differences regarding lifestyle and
diet, etc. (Senior and Bhopal, 1994). Nonetheless, we believed it
sufficiently important to study disease patterns in this group as a
whole to warrant the development of a robust methodology for the
identification of south Asian names. The pilot study undertaken as
a validation exercise suggested acceptable sensitivity and speci-
ficity levels for the Nam Pehchan computer software package
alone. By combining Nam Pehchan with a range of additional
inspection methods, further improvements in accuracy are clearly
achievable. The methods outlined could be applied in other situa-
tions in which named data are available. Some misclassification of
names is likely to have occurred and different methods were used
to identify south Asians in the numerator and denominator, but,
unless this has led to a disproportionate underestimation or overes-
timation in either, the rates presented will be sufficiently unbiased.
With the final classification of names as reference, the sensi-
tivity (90.5%) and specificity (99.4%) achieved by Nam Pehchan
were very close to the values obtained in the pilot study (91.0%
and 99.0% respectively) in which ethnicity had been identified by
a specialist tumour registry. The lower positive predictive value
(63.2%) compared with the pilot study (87.5%) was due, in part, to
the higher proportion of names classified as south Asian by Nam
Cancer incidence among south Asians in England 651
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Figure 1 Age-specific incidence rates (males) per 100 000 person–years
(1990–92) for all sites (ICD9: 140–208), excluding non-melanoma skin
cancer (ICD9: 173)
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Figure 2 Age-specific incidence rates (females) per 100 000 person–years
(1990–92) for all sites (ICD9: 140–208), excluding non-melanoma skin
cancer (ICD9: 173)652 H Winter et al
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Pehchan which were considered to be of non-south Asian ethnic
origin. The distinction between Moslem names of south Asian and
non-south Asian ethnic origin is an area of potential difficulty.
Census data indicated that the vast majority of Moslem names
under consideration in the current study would be of south Asian
ethnic origin. Further, a substantial proportion of the Moslem
names classified as non-south Asian were readily identifiable as
being of Arab or Turkish rather than south Asian ethnic origin.
Nevertheless, it is possible that a small number of Moslem names
common to both south Asian and non-south Asian populations will
have been misclassified. Names considered to be of Sri Lankan
origin were not included in the south Asian classification as Nam
Pehchan was unable to accurately classify names of Sinhalese
origin. Tamil names are common to both Sri Lanka and south India
and it is, therefore, possible that a few names of Sri Lankan origin
will have been included in the south Asian classification.
This study provides the most accurate and precise estimates of
cancer incidence in the English south Asian population to date.
Overall, standardized rates for English south Asians were signifi-
cantly lower than non-south Asian rates. The higher rates for
English south Asians compared with Indian Asians for a number
of common sites, including the colon, lung, female breast,
lymphoma and leukaemia, suggests that substantial detrimental
modifications in exposure and lifestyle have occurred in the
migrant south Asian population.
The burden of malignant disease in the English south Asian
population currently shows considerable differences from the
burden of disease in the non-south Asian population (Tables 3 and
4). These differences, in part, result from the younger age structure
of the English south Asian population. Approximately 50% of 
the English south Asian study population were aged under 25
compared with approximately 33% of the non-south Asian popula-
tion. Nevertheless, consideration of age-specific rates (Tables 5
and 6) suggests that differences in underlying incidence also exist.
For example, the greater relative importance of lymphoma in south
Asian males is due to its greater relative importance across all age
groups and not just higher rates in those aged 0—14.
Age-standardized rates are presented (Tables 1 and 2) to allow
comparisons between English south Asian, non-south Asian and
Indian Asian rates. As a weighted sum of age-specific rates, stan-
dardized rates may conceal more complex underlying age-specific
patterns. Nevertheless, the rates presented serve as a useful
summary of cancer incidence in both the English south Asian and
non-south Asian study populations.
A comparison of these results with those from an earlier study
on cancer mortality in migrants to England and Wales who were
born in the Indian subcontinent (Swerdlow et al, 1995) shows
significantly raised south Asian rates, in both studies, for
Hodgkin￿s disease in males, cancer of the oral cavity, oesophagus
and leukaemia in females, and for cancer of the pharynx (except
nasopharynx), liver and gall bladder in both sexes. Rates for
thyroid cancer were significantly raised in south Asian males in
the mortality study and in south Asian females in the current study.
Although the mortality study also found raised south Asian rates
for cancer of the oesophagus and pancreas in males, and cervical
cancer in females, the current study found significantly lower
south Asian rates at these sites. The absence of population denom-
inators and inclusion of only those south Asians born in the Indian
subcontinent in the mortality study might explain some of the
main differences between the results of the two studies. In addi-
tion, differences between incidence and mortality rates may reflect
differences in the survival experience of south Asians and non-
south Asians.
The comparison of rates between English south Asians and
Indian Asians requires caution for the following reasons.
(1) The data on English south Asians cover the period 1990—92
and are based on a population split of approximately 61%
Indian, 28% Pakistani and 11% Bangladeshi, whereas the
data on Indian Asians cover the period 1983—87 and are
based on four regional Indian populations.
(2) No detailed published data were available for Pakistan and
Bangladesh.
(3) A substantial proportion of the migration to the United
Kingdom from the Indian subcontinent has been from
specific regions such as Mirpur in Pakistan and the Punjab in
India. The cancer experience in these areas may not be the
same as in those covered by the Indian cancer registries.
(4) Further, migrants may not be typical of the resident popula-
tion in the country of ethnic origin.
(5) There may also be differences in registration practice
between registries in the United Kingdom and those in India.
(6) Differences in medical practice between the United Kingdom
and the Indian subcontinent will influence the reported inci-
dence of cancer. Incidence rates will reflect the rates at
which incidental cancers are discovered by invasive proce-
dures. For example, prostate cancer rates will partly depend
on the use of biopsies as a diagnostic tool.
(7) There may also be important differences with regard to
access and uptake of health services between the United
Kingdom and the Indian subcontinent.
Although the above considerations need to be taken into
account, the comparison between Indian Asian and English south
Asian rates, nevertheless, serves as a starting point for an assess-
ment of the potential effect of migration on the south Asian
population. Bombay cancer registry data were used for the
comparison of age-specific rates in Figures 1 and 2 as it is the
oldest and largest of the cancer registries in the Indian sub-
continent.
The English south Asian population differs from the non-south
Asian population both in terms of age distribution and with regard
to a range of cultural and socioeconomic factors. There may be
ethnic differences with regard to access and uptake of health
services that impact on cancer registration. One simple indicator of
the quality of cancer registration data is provided by the
percentage of cases registered as primary site uncertain. The lower
figures for south Asians (5.3% male and 5.7% female) compared
with non-south Asians (6.5% male and 6.8% female) suggest that
any differences between the two groups relate primarily to age
structure rather than differences in the uptake of services and
cancer registration practices. Old and frail patients are less likely
to be intensively investigated and more likely to be registered as
primary site uncertain.
Data from the 1991 census yielded the following approxima-
tions for the percentage of English south Asian males (females)
born in the United Kingdom: 84% (87%) for ages 0—19, 40%
(35%) for ages 20—29, and 3% (4%) for ages 30+. For adults aged
30 and over, their overall cancer risk remained closer to that of the
Bombay population. However, English south Asians aged under
30, who represent the first generation to include a substantial
proportion born in the United Kingdom, experienced similar or
even higher cancer incidence rates than non-south Asians. Thesefigures suggest that the transition from the lower overall cancer
risk of the country of ethnic origin to that of the country of resi-
dence is currently more marked in those age groups which include
a substantial proportion born in the United Kingdom.
The lower rate for cervical cancer in English south Asians
compared with non-south Asians largely resulted from lower rates
in the younger age groups (0—49 years), because English south
Asian rates in the older age groups (50+ years) were generally
higher, suggesting that a cohort effect may be present. A cohort
effect may also be present in the English south Asian female breast
cancer rates, as younger English south Asian women (20—29
years) had higher age-specific rates than their non-south Asian
counterparts (10.1 compared with 6.7 per 100 000 person years for
ages 25—29). The upper limit of this age range (29 years) also
represented the upper limit of the age groups containing a signifi-
cant proportion of individuals born in the United Kingdom. This
implies that this cohort requires careful monitoring. Low breast
and cervical screening rates among English south Asian women
(Hoare, 1996) cannot be viewed with complacency.
English south Asian rates for the tongue, mouth and hypo-
pharynx were lower than Indian Asian rates, but higher than non-
south Asian rates. This would be consistent with a change in
behavioural risk factors, primarily the chewing of tobacco with
betel-quid (Tomatis et al, 1990). The greater reduction and lower
rates in English south Asian males compared with females is
consistent with a report that found that a significantly higher
proportion of females compared with males, in at least one of the
English south Asian communities (Bangladeshi), included tobacco
as a betel-quid chew ingredient (Bedi, 1996).
A number of the findings from this study may be worthy of
further investigation. For example:
(1) The lower rate of oesophageal cancer in English south Asian
males and higher rate in English south Asian females
compared with non-south Asians. These differences may be
partly explained by differences between south Asians and
non-south Asians and between sexes in the rates of squamous
cell carcinoma and adenocarcinoma of the oesophagus.
(2) The higher rates of liver and gall bladder cancer in English
south Asians compared with non-south Asians. The higher
rate of liver cancer in the English south Asian population
may be associated with higher levels of hepatitis B infection.
(3) The rate of lymphoma in English south Asian males is higher
than the non-south Asian rate and almost treble the highest
Indian Asian rate. The transition from lower Indian Asian rates
to higher non-south Asian rates is, at present, more marked for
lymphoma than for any other type of cancer. Further, English
south Asian male rates are similar to or higher than non-south
Asian rates across all age groups (Table 5). This is consistent
with an infectious component in the aetiology of lymphoma.
In this study, English south Asians currently exhibit a lower
overall cancer risk than non-south Asians. The distribution of age-
specific rates for all sites combined, however, gives no cause to
assume that this situation will persist. The comparison with Indian
registries suggests that exposures associated with common Western
cancers have increased. Reductions in the rates of cancer of the oral
cavity, pharynx and cervix, although important, do not compensate
for these increases. Efforts should be made to modify the adoption
of harmful behaviours in this group. It is, therefore, important that
English south Asians are targeted in health promotion activities
relating to common cancers. The excesses described at certain sites
in English south Asians highlight the need for specific preventative
interventions within these communities. For sites where differences
exist which have not been explained, further studies in this popula-
tion may provide insight into the aetiology of the conditions.
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